|
1. Marjani M. [Epidemiology and risk factors of ovarian cancer]. Iran J Obstet Gynecol Infertil. 2010; 5(3): 67-73. [Article in Persian] 2. Noori-Daloii MR, Rashvand Z. [Molecular Genetics and Gene Therapy in Ovarian Cancer]. Horizon Med Sci. 2010; 16(3): 5-19. [Article in Persian] 3. Folkman J. Angiogenesis and breast cancer. J Clin Oncol. 1994 Mar; 12(3): 441-43. DOI: 10.1200/jco.1994.12.3.441 4. Banerjee S, Kaye SB. New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential. Clin Cancer Res. 2013 Mar; 19(5): 961-68. DOI: 10.1158/1078-0432.CCR-12-2243 5. Aminimoghaddam S, Norouzi S. [Ovarian failure due to cancer treatment and fertility preservation options]. Tehran Univ Med J. 2016; 74(1): 1-8. [Article in Persian] 6. Mousavi A, Karimi-Zarchi M, Behtash N, Mokhtari-Gorgani M, Mehrdad N, Rouhi M, et al. [The effect of consolidation treatment with intraperitoneal carboplatin in advanced epithelial ovarian cancers]. Tehran Univ Med J. 2014; 72(4): 215-21. [Article in Persian] 7. Sreekumar S, Sithul H, Muraleedharan P, Azeez JM, Sreeharshan S. Pomegranate Fruit as a Rich Source of Biologically Active Compounds. Biomed Res Int. 2014; 2014: 686921. DOI: 10.1155/2014/686921 8. Masoumi Moghaddam S, Amini A, Morris DL, Pourgholami MH. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev. 2012 Jun; 31(1-2): 143-62. DOI: 10.1007/s10555-011-9337-5 9. Sarkhosh A, Zamani Z, Fatahi R, Hassani ME, Wiedow C, Buck E, et al. Genetic diversity of Iranian soft-seed pomegranate genotypes as revealed by fluorescent-AFLP markers. Physiol Mol Biol Plants. 2011 Jul; 17(3): 305-11. DOI: 10.1007/s12298-011-0070-x 10. Zamani Z. [Characteristics of Pomegranate Cultivars Grown in Saveh of Iran]. MSc Thesis. University of Tehran. 1990. [Persian] 11. Song B, Li J, Li J. Pomegranate peel extract polyphenols induced apoptosis in human hepatoma cells by mitochondrial pathway. Food Chem Toxicol. 2016 Jul; 93: 158-66. DOI: 10.1016/j.fct.2016.04.020 12. Loizzi V, Del Vecchio V, Gargano G, De Liso M, Kardashi A, Naglieri E, et al. Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer. Int J Mol Sci. 2017 Sep; 18(9) pii: E1967. DOI: 10.3390/ijms18091967 13. Choi HJ, Armaiz Pena GN, Pradeep S, Cho MS, Coleman RL, Sood AK. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev. 2015 Mar; 34(1): 19-40. DOI: 10.1007/s10555-014-9538-9 14. Keshavarzi M, Esfandani Bozchaloyi S, Kiarostami K. [Pharmagnosy, total phenolic and flavonoid contents and investigation on antioxidant properties of stem and leaf extracts of 6 Stellaria species and two related genera in Iran]. Applied Biology. 29(1): 143-58. [Article in Persian] 15. Yang H, Dou QP. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr Drug Targets. 2010 Jun; 11(6): 733-44. 16. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science. 2010 Oct; 330(6000): 70-74. DOI: 10.1126/science.1191652 17. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000 Oct; 48(10): 4581-89. DOI: 10.1021/jf000404a 18. Mehta R, Lansky EP. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev. 2004 Aug; 13(4): 345-48. DOI: 10.1097/01.cej.0000136571.70998.5a 19. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol. 2009 Jun; 27(16): 2712-25. DOI: 10.1200/JCO.2008.20.6235 20. Faria A, Calhau C. The bioactivity of pomegranate: impact on health and disease. Crit Rev Food Sci Nutr. 2011 Aug; 51(7): 626-34. DOI: 10.1080/10408391003748100 21. Askari M, Nikoonahad Lotfabadi N. [Evaluation of niosomal nano-carriers capabilities on toxicity preservation and delivery of pomegranate peel extract in cell culture conditions (MCF-7 cell line of breast cancer)]. Daneshvar. 2018; 26(5): 9-20. [Article in Persian] 22. Lee CJ, Chen LG, Liang WL, Wang CC. Anti-inflammatory effects of Punica granatum Linne invitro and in vivo. Food Chemistry. 2010; 118(2): 315-22. DOI: 10.1016/j.foodchem.2009.04.123 23. Dana N, Javanmard SH, Rafiee L. Antiangiogenic and antiproliferative effects of black pomegranate peel extract on melanoma cell line. Res Pharm Sci. 2015 Mar-Apr; 10(2): 117–24.
|
